Group One Trading’s ProShares Ultra CRCL CRCA Stock Holding History

Group One Trading’s Portfolio CRCA Stock Details CRCA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.08M	Buy	+50,300	New	+$2.09M	﹤0.01%	2042

Other funds holding CRCA

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

SG Americas Securities New York $92.9B AUM 36.98% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Group One Trading's CRCA Position: Q1 2026 in Review

Group One Trading reduced its ProShares Ultra CRCL (CRCA) stake by 89% in Q1 2026, selling an estimated $36.3K and leaving 106 shares worth $4.38K. The position accounts for ﹤0.01% of the portfolio, ranked #6761.

Group One Trading first reported a position in CRCA in Q3 2025 and has held it in 3 quarters since. The position peaked at $159K in Q3 2025. 7 funds tracked by Wall St. Rank hold CRCA as of Q1 2026.

Group One Trading held 106 shares of ProShares Ultra CRCL worth $4.38K as of Q1 2026.
Group One Trading sold 875 ProShares Ultra CRCL shares in Q1 2026, an estimated $36.3K.
ProShares Ultra CRCL made up ﹤0.01% of Group One Trading's portfolio in Q1 2026, its #6761 holding.
Group One Trading first reported a position in ProShares Ultra CRCL in Q3 2025 and has held it in 3 quarters since.
Group One Trading's ProShares Ultra CRCL position peaked at $159K in Q3 2025.
7 funds tracked by Wall St. Rank held ProShares Ultra CRCL as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.